Melanoma central nervous system metastases: current approaches, challenges, and opportunities-Reference-Cited by-同舟云学术

Melanoma central nervous system metastases: current approaches, challenges, and opportunities

Published:2016-10-22 Issue:6 Volume:29 Page:627-642
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Cohen Justine V.¹,Tawbi Hussain²,Margolin Kim A.³,Amravadi Ravi⁴,Bosenberg Marcus¹,Brastianos Priscilla K.⁵,Chiang Veronica L.¹,de Groot John⁶,Glitza Isabella C.²,Herlyn Meenhard⁷,Holmen Sheri L.⁸,Jilaveanu Lucia B.¹,Lassman Andrew⁹,Moschos Stergios¹⁰,Postow Michael A.¹¹,Thomas Reena¹²,Tsiouris John A.¹³,Wen Patrick¹⁴,White Richard M.¹⁵,Turnham Timothy¹⁶,Davies Michael A.²,Kluger Harriet M.¹

Affiliation:

1. Yale Cancer Center; Yale School of Medicine; New Haven CT USA

2. Department of Melanoma; Medical Oncology; University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Medical Oncology & Therapeutics Research; City of Hope Cancer Center; Duarte CA USA

4. Abramson Cancer Center; University of Pennsylvania; Philadelphia PA USA

5. Division of Neuro-Oncology; Massachusetts General Hospital; Boston MA USA

6. Division of Neuro-Oncology; MD Anderson Cancer Center; Houston TX USA

7. Melanoma Research Center; The Wistar Institute; Philadelphia PA USA

8. Huntsman Cancer Institute; University of Utah Health Sciences Center; Salt Lake City UT USA

9. Department of Neurology & Herbert Irving Comprehensive; Cancer Center; Columbia University Medical Center; New York NY USA

10. UNC Lineberger Comprehensive Cancer Center; University of North Carolina at Chapel Hill; Chapel Hill NC USA

11. Department of Oncology; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine; New York NY USA

12. Division of Neuro-Oncology; Department of Neurology; Stanford University; Stanford CA USA

13. Department of Radiology; New York-Presbyterian Hospital - Weill Cornell Medicine; New York NY USA

14. Department of Neuro-Oncology; Dana-Farber Cancer Institute; Boston MA USA

15. Department of Cancer Biology & Genetics; Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine; New York NY USA

16. Melanoma Research Foundation; Washington DC USA

Funder

Bristol-Myers Squibb

Karyopharm

ORIC Pharmaceuticals

Sanofi-Aventis Korea Company

Regeneron Pharmaceuticals

Vascular Biogenics

Myriad

Oncothyreon

Novartis

Merck

Agios

Angiochem

Astra Zeneca

Exelixis

Genentech/Roche

GlaxoSmithKline

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12538/fullpdf

Reference141 articles.

1. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study;Agarwala;J. Clin. Oncol.,2004

2. Evolving treatment options for melanoma brain metastases;Ajithkumar;Lancet Oncol.,2015

3. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004

4. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT);Armstrong;J. Neurooncol.,2006

5. Patterns of response and progression in patients with BRAF-mutant melanoma metastatic to the brain who were treated with dabrafenib;Azer;Cancer,2014

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Baseline 18F-FDG PET/CT to Predict Brain Metastasis Development in Melanoma Patients;Cancers;2023-12-26

2. Impact of Immune Checkpoint Inhibitor Therapy on Quality of Life in Patients With Advanced Melanoma;Cancer Nursing;2023-11-16

3. Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis;Cancers;2023-11-02

4. Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression;Cancers;2023-10-13

5. Factors influencing the prognosis in Braf wild-type metastatic malignant melanoma and the role of novel inflammation indices;TURKDERM;2023-10-02